Gilead has not yet named a price for remdesivir yet. Photo: Liu Guanguan/China News Service via Getty Images

A fair price for Gilead's coronavirus drug, remdesivir, likely should not exceed $2,800 for a course of treatment, according to updated estimates from experts at the Institute for Clinical and Economic Review.

The bottom line: Gilead hasn't released a final price for remdesivir yet, and it could set the bar for other coronavirus treatments that come after it.

Details: ICER — which conducts cost-effectiveness analyses on drugs and other medical treatments — originally released remdesivir price estimates in May, but revised its figures as more information has come out:

  • $10 per treatment: Same low-end estimate assumes recovery of basic costs plus a small margin.
  • $310 per treatment: This price reflects the drug's current clinical benefit, which reduces hospitalization time but does not reduce the chance of death. (If the drug shows a mortality benefit later, this could go up to $5,000.)
  • $600 per treatment: Roughly what generic drug companies are charging for remdesivir overseas.
  • $1,600 per treatment: If Gilead tried to recoup new research costs.
  • $2,800 per treatment: This assumes dexamethasone becomes the new standard for hospitalized coronavirus patients, and "therefore the overall lives and life years saved with remdesivir are lower," ICER said.

Go deeper

6 hours ago - Health

Trump administration invests $2 billion in coronavirus drugs

A Novavax researcher prepares to test the vaccine. Photo: Andrew Caballero-Reynolds/AFP via Getty Images

The Department of Health and Human Services and Department of Defense have awarded $1.6 billion to Novavax and $450 million to Regeneron Pharmaceuticals as part of the federal government's efforts to speed up the development of coronavirus treatments.

The bottom line: Federal scientists are holding out hope that these companies' treatments, along with other vaccines in development, will snuff out the spread of the coronavirus.

Updated 41 mins ago - Politics & Policy

Mary Trump book: How she leaked Trump financials to NYT

Simon & Schuster

In her new memoir, President Trump's niece reveals how she leaked hordes of confidential Trump family financial documents to the New York Times in an effort to expose her uncle, whom she portrays as a dangerous sociopath.

Why it matters: Trump was furious when he found out recently that Mary Trump, a trained psychologist, would be publishing a tell-all memoir. And Trump's younger brother, Robert, tried and failed to block the publication of "Too Much and Never Enough: How My Family Created the World's Most Dangerous Man."

Updated 52 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Eniola Odetunde/Axios

  1. Global: Total confirmed cases as of 3:30 p.m. ET: 11,691,068 — Total deaths: 540,062 — Total recoveries — 6,349,542Map.
  2. U.S.: Total confirmed cases as of 3:30 p.m. ET: 2,963,244 — Total deaths: 130,813 — Total recoveries: 924,148 — Total tested: 36,225,015Map.
  3. 2020: Biden releases plan to strengthen coronavirus supply chain.
  4. Congress: Trump administration notifies Congress of intent to withdraw from WHO.
  5. Public health: Fauci says it's a "false narrative" to take comfort in lower coronavirus death rate.
  6. World: Brazil's President Bolsonaro tests positive— India reports third-highest case count in the world.